FARALLON CAPITAL MANAGEMENT LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2021$13,452,000
-21.4%
300,0000.0%0.07%
-35.0%
Q4 2020$17,121,000
+1.1%
300,000
-9.1%
0.10%
-12.0%
Q3 2020$16,929,000
-60.4%
330,000
-53.8%
0.12%
-65.8%
Q2 2020$42,700,000
+3.7%
715,000
-28.5%
0.34%
-3.1%
Q1 2020$41,170,000
-30.4%
1,000,000
+5.3%
0.35%
-11.5%
Q4 2019$59,128,000
+132.3%
950,000
+26.7%
0.40%
+107.8%
Q3 2019$25,455,000
+1240.4%
750,000
+650.0%
0.19%
+1029.4%
Q3 2017$1,899,000100,0000.02%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders